Delivery Order SPE2DB25D3005-SPE2DB25FQFZZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $32,943.62 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL units. This competitively awarded, firm fixed price contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a widely used biologic medication for treating autoimmune conditions including rheumatoid arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,476.54 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of April 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,063.60 on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single-item pharmaceutical procurement with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,574.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract was awarded on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and utilizes firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order....
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,837.26 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with a completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As the prime awardee,...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQFZZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has consistently demonstrated capability to meet federal procurement requirements through competitive awards across diverse medical supply categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/16/25 |